Nobivac® DHPPi

Active Ingredients
A live attenuated freeze-dried vaccine containing canine distemper virus, canine adenovirus (CAV-2), canine parvovirus (C154) and canine parainfluenza virus.

Indications 
Active immunisation of healthy dogs against canine distemper virus, canine adenovirus type 1 (infectious canine hepatitis), canine parvovirus and against canine cough caused by canine adenovirus type 2 and canine parainfluenza virus.

• The puppy programme can be completed from a minimum of 10 weeks of age
• The components of Nobivac DHPPi have been shown to protect against canine distemper virus, canine parvovirus and canine adenovirus for at least three years.
• Onset of immunity is one week after administration for canine distemper virus, canine parvovirus and canine adenovirus.
• For the canine parainfluenza component, annual vaccination is recommended. Onset of immunity is four weeks.
• Nobivac DHPPi can be used in pregnant bitches.

Dosage
Reconstitute each single dose vial of the vaccine with one vial of Nobivac diluent or Nobivac Lepto I and administer by subcutaneous injection.

Each of the Nobivac vaccines fits into a larger overall vaccination programme. The individual’s age, health (including maternal immunity) and local environmental conditions should be considered in the formulation of a vaccination programme.

Suggested Vaccination Protocol 

1. Vaccination commencing at 6- 8 weeks of age. (Two doses)

*Core vaccination for dogs, CPV, CDV and CAV. **Puppies must be a minimum of 10 weeks of age at final vaccination. 

 2. Vaccination commencing at 10 weeks of age or older. (One dose) 

AVCM No: A6257     
AVAILABLE ONLY UNDER VETERINARY AUTHORISATION 

Additional Information
Pack Size: 10 x 1 dose carton